Centenarians provide genetic clue to
age-related disease
23 January 2003 17:00 GMT
by Sabine Louët
Studies
on people who have passed their hundredth birthday are revealing the role
that genetics plays in age-related disease. Many age-related diseases
result from inflammatory processes, and centenarians enjoy unusually low
inflammatory profiles, says Italian immunologist, Claudio Franceschi.
Franceschi, professor of immunology at the University of Bologna,
Italy, says that his work on centenarians has revealed a genetic link
between a mechanism for chronic inflammation and aging. "People are prone
to develop inflammation on a genetic basis," he said.
Franceschi discovered that centenarians present low levels of the
pro-inflammatory cytokine interleukin 6 (IL-6) and high levels of the
anti-inflammatory cytokine IL-10. High levels of IL-6, which is produced
in muscles and bones, is related to loss of muscle mass and power with
age. Such status translates into frailty and disability and the occurrence
of diseases such as osteoporosis.
"There is a balance between pro- and anti-inflammatory compounds [that
is] genetically controlled," Franceschi told delegates at last month's
Biochemical Society meeting held at Imperial College in London. People
with certain genes that trigger an imbalance between a pro- and an
anti-inflammatory cytokine are more likely to suffer from chronic
inflammation related to ageing, he says.
Although 25% to 30% of longevity is due to a genetic background, says
Efstathios Gonos, director of research specialised in ageing at the
National Hellenic Research Foundation in Athens, "It is extremely unlikely
that there is a single gene causing longevity."
The genetic make up of centenarians can thus provide a useful tool in
the investigation of age-related diseases. Indeed, Franceschi brands
centenarians "extreme phenotypes" that comprise all the genetic elements
necessary to avoid age-related diseases. Conversely, high IL-6 levels can
be considered as a genetic marker for morbidity and mortality in the
elderly.
This does not come as a surprise to researcher of age-related diseases
Jonathan Powell, from Unilever Research in the UK. Pro-inflammatory
cytokine IL-6 is not only linked to the immune system. It is also a major
metabolic regulator found in primitive organisms such as tubeworms and
starfish, which have no immune system. "IL-6 has acquired some other
functionality as we have evolved. But those old metabolic functions are
still there in us," said Powell.
"As more and more and more of these associations are found, we'll have
a better idea of the predictive value of those genotypes," he said.
Genetic markers could then, one day, help in identifying subjects at
higher risk, and of a new preventative medicine. "Inflammation does not
describe all of ageing but it has a significant component, " said Powell.
"Major age-related diseases all share an inflammatory pathogenesis,"
said Franceschi. Different diseases such as arthritis and Alzheimer's
disease share the same inflammatory mechanism, he adds. People treated
with anti-inflammatory compounds for arthritis have a lower risk of
getting Alzheimer's.
The finding of a genetic susceptibility to age-related disease also
fits with an evolutionary perspective. Centenarians present low levels of
pro-inflammatory cytokine IL-6, which protects them from age-related
inflammatory diseases. According to Franceschi, showing a strong
inflammatory response is an advantage before the age of 50 but it is
detrimental in later life when the reproduction-driven force of evolution
decreases. "From an evolutionary perspective, the objective is not to live
long but to be fit enough to reproduce", agreed Gonos.
In addition, Franceschi has identified a difference in cytokine levels
between men and women. He believes that genetics plays a greater role in
protecting men from inflammatory disease than protecting women, because
women have more protective hormones. "Women are less prone to having high
inflammatory status because it is detrimental for bearing children," he
said.

|
Send us your
comments for publication.
|
| Sign up for BioMedNet News weekly
email alerts. |